Why is the biomarker NfL important for people with ALS? The value of the biomarker Neurofilament light chain (NfL) in the blood is suitable for assessing the progression and therapy of ALS. A
we have added some new features to the ALS app and improved the user experience. The latest update of the ALS app version 4.0 is available for free download in the Apple App Store and Google
More than 1,100 people with amyotrophic lateral sclerosis (ALS) are currently participating in the study “NF-L in ALS”, which is made possible by the Boris Canessa ALS Foundation
